Three Biotechs That Takeover: Top 2026 M&A Targets
As large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
This intro covers scenarios where a price-weighted index may be appropriate and how it contrasts with alternative indexing methods.
22,669 articlesAs large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
SBI Holdings plans two ETFs, including Japan's first XRP product, aiming to attract billions in assets as Japan updat...
Anthropic confirms a high-profile hire from Tesla's AI team, expanding its competitive edge in the AI race. The move ...
Truth Social’s spot Bitcoin ETF has withdrawn its S-1 filing, signaling tougher market conditions for plain-vanilla c...
Illinois regulators approve a sweeping regulatory framework for home equity investments, drawing praise from CHEP as ...
Vice President JD Vance publicly pushed back on questions about President Trump's stock trading, arguing that the bil...
AI infrastructure bets push a trillion-dollar spending agenda, yet water-use concerns from almond farming and local o...
April data show a split in new construction: multifamily projects surged while single-family starts declined, leaving...
Mortgage lenders are shifting from deal-by-deal momentum to long-term advisory relationships, redefining growth in a ...
IMAX bucked trend as cinema operators fade; investors eye the premium-format chain's sale.
A leaked Meta audio from an April 30 all-hands meeting signals a shift toward leveraging compute and internal output ...
When regulatory headlines hit a fintech stock, prices can swing wildly. This article unpacks the futu stock plunged r...